Tekovirimat (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tekovirimat" in Malay language version.

refsWebsite

Global rank Malay rank

20web.archive.org

1^st place

14nih.gov

4^th place

14^th place

9doi.org

2^nd place

8^th place

7wikipedia.org

low place

4europa.eu

68^th place

197^th place

4cdc.gov

218^th place

90^th place

3siga.com

low place

2canada.ca

1,712^th place

4,938^th place

2fda.gov

447^th place

467^th place

1hres.ca

low place

1nytimes.com

7^th place

44^th place

1sciencenews.org

3,410^th place

986^th place

1espacenet.com

800^th place

5,553^rd place

1clinicaltrials.gov

5,225^th place

low place

1contagionlive.com

low place

canada.ca

"Notice: Multiple Additions to the Prescription Drug List (PDL) [2022-01-24]". Health Canada. 24 Januari 2022. Diarkibkan daripada yang asal pada 29 Mei 2022. Dicapai pada 28 Mei 2022.
"New Medicines Approved in 2018". Health Canada. 15 Januari 2020. Diarkibkan daripada yang asal pada 29 Mei 2022. Dicapai pada 28 Mei 2022.

cdc.gov

"Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (42): 943–946. October 2019. doi:10.15585/mmwr.mm6842a2. PMC 6812835. PMID 31647789. Diarkibkan daripada yang asal (PDF) pada 2 Ogos 2022. Dicapai pada 2 Ogos 2022. Unknown parameter |displayauthors= ignored (bantuan)
"Information for Healthcare Providers on Obtaining and Using TPOXX (Tecovirimat) for Treatment of Monkeypox". U.S. Centers for Disease Control and Prevention (CDC). 22 Julai 2022. Diarkibkan daripada yang asal pada 31 Julai 2022. Dicapai pada 1 Ogos 2022.

emergency.cdc.gov

"Steps for Clinicians to Order Medication to Treat Monkeypox". Coca Now. 19 Julai 2022. Diarkibkan daripada yang asal pada 2 Ogos 2022. Dicapai pada 24 Julai 2022.
"Monkeypox Outbreak: Updates on the Epidemiology, Testing, Treatment, and Vaccination" (PDF). U.S. Centers for Disease Control and Prevention. Diarkibkan (PDF) daripada yang asal pada 2 Ogos 2022. Dicapai pada 27 Julai 2022.

clinicaltrials.gov

National Institute of Allergy and Infectious Diseases (NIAID) (12 September 2022). "A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Monkeypox Virus Disease". SIGA Technologist. Diarkibkan daripada yang asal pada 20 September 2022. Dicapai pada 16 September 2022.

contagionlive.com

"Trial Launching to Study Tecovirimat as Monkeypox Treatment". Contagion Live (dalam bahasa Inggeris). 16 September 2022. Diarkibkan daripada yang asal pada 16 September 2022. Dicapai pada 16 September 2022.

doi.org

"Waking up to monkeypox". BMJ. 377: o1321. May 2022. doi:10.1136/bmj.o1321. PMID 35613732 Check |pmid= value (bantuan).
"Clinical features and management of human monkeypox: a retrospective observational study in the UK". The Lancet. Infectious Diseases. 22 (8): 1153–1162. May 2022. doi:10.1016/S1473-3099(22)00228-6. PMC 9300470 Check |pmc= value (bantuan). PMID 35623380 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Oral Tecovirimat for the Treatment of Smallpox". The New England Journal of Medicine. 379 (1): 44–53. July 2018. doi:10.1056/NEJMoa1705688. PMC 6086581. PMID 29972742. Unknown parameter |displayauthors= ignored (bantuan)
"Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (42): 943–946. October 2019. doi:10.15585/mmwr.mm6842a2. PMC 6812835. PMID 31647789. Diarkibkan daripada yang asal (PDF) pada 2 Ogos 2022. Dicapai pada 2 Ogos 2022. Unknown parameter |displayauthors= ignored (bantuan)
"Are we there yet? The smallpox research agenda using variola virus". PLOS Pathogens. 10 (5): e1004108. May 2014. doi:10.1371/journal.ppat.1004108. PMC 4006926. PMID 24789223.
"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge". Journal of Virology. 79 (20): 13139–13149. October 2005. doi:10.1128/JVI.79.20.13139-13149.2005. PMC 1235851. PMID 16189015. Unknown parameter |displayauthors= ignored (bantuan)
"Re-examination of the Cycloaddition of Cycloheptatriene with Maleic Anhydride". Bulletin of the Chemical Society of Japan. 44 (11): 2993–3000. 1971. doi:10.1246/bcsj.44.2993.
"Review of the Patent Literature: Synthesis and Final Forms of Antiviral Drugs Tecovirimat and Baloxavir Marboxil". Organic Process Research & Development. 23 (7): 1298–1307. 2019. doi:10.1021/acs.oprd.9b00144.
"Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor". Antimicrobial Agents and Chemotherapy. 52 (5): 1721–1727. May 2008. doi:10.1128/AAC.01303-07. PMC 2346641. PMID 18316519. Unknown parameter |displayauthors= ignored (bantuan)

espacenet.com

worldwide.espacenet.com

AU patent 2004249250, Bailey, Thomas R.; Jordan, Robert & Rippin, Susan R., "Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases", published 2004-12-29, assigned to Siga Pharmaceuticals Inc

europa.eu

ema.europa.eu

"Tecovirimat Siga EPAR". European Medicines Agency. 10 November 2021. Diarkibkan daripada yang asal pada 16 Mei 2022. Dicapai pada 23 April 2022.
"Tecovirimat Siga: Pending EC decision". European Medicines Agency. 11 November 2021. Diarkibkan daripada yang asal pada 13 November 2021. Dicapai pada 13 November 2021.
"Summary of Product Characteristics" (PDF). European Medicines Agency. Diarkibkan (PDF) daripada yang asal pada 21 Mei 2022. Dicapai pada 24 Mei 2022.

ec.europa.eu

"Tecovirimat Siga Product information". Union Register of medicinal products. Dicapai pada 3 Mac 2023.

fda.gov

"FDA approves the first drug with an indication for treatment of smallpox" (Siaran akhbar). 13 Julai 2018. Diarkibkan daripada yang asal pada 23 April 2019. Dicapai pada 1 Ogos 2018.
Office of the Commissioner (24 Mac 2020). "Press Announcements - FDA approves the first drug with an indication for treatment of smallpox". Food and Drug Administration (FDA). Diarkibkan daripada yang asal pada 23 April 2019. Dicapai pada 14 Julai 2018.

hres.ca

hpr-rps.hres.ca

"Summary Basis of Disision (SBD) for Tpoxx". Health Canada. 23 Oktober 2014. Diarkibkan daripada yang asal pada 29 Mei 2022. Dicapai pada 29 Mei 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

"Waking up to monkeypox". BMJ. 377: o1321. May 2022. doi:10.1136/bmj.o1321. PMID 35613732 Check |pmid= value (bantuan).
"Clinical features and management of human monkeypox: a retrospective observational study in the UK". The Lancet. Infectious Diseases. 22 (8): 1153–1162. May 2022. doi:10.1016/S1473-3099(22)00228-6. PMC 9300470 Check |pmc= value (bantuan). PMID 35623380 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Oral Tecovirimat for the Treatment of Smallpox". The New England Journal of Medicine. 379 (1): 44–53. July 2018. doi:10.1056/NEJMoa1705688. PMC 6086581. PMID 29972742. Unknown parameter |displayauthors= ignored (bantuan)
"Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (42): 943–946. October 2019. doi:10.15585/mmwr.mm6842a2. PMC 6812835. PMID 31647789. Diarkibkan daripada yang asal (PDF) pada 2 Ogos 2022. Dicapai pada 2 Ogos 2022. Unknown parameter |displayauthors= ignored (bantuan)
"Are we there yet? The smallpox research agenda using variola virus". PLOS Pathogens. 10 (5): e1004108. May 2014. doi:10.1371/journal.ppat.1004108. PMC 4006926. PMID 24789223.
"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge". Journal of Virology. 79 (20): 13139–13149. October 2005. doi:10.1128/JVI.79.20.13139-13149.2005. PMC 1235851. PMID 16189015. Unknown parameter |displayauthors= ignored (bantuan)
"Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor". Antimicrobial Agents and Chemotherapy. 52 (5): 1721–1727. May 2008. doi:10.1128/AAC.01303-07. PMC 2346641. PMID 18316519. Unknown parameter |displayauthors= ignored (bantuan)

ncbi.nlm.nih.gov

"Clinical features and management of human monkeypox: a retrospective observational study in the UK". The Lancet. Infectious Diseases. 22 (8): 1153–1162. May 2022. doi:10.1016/S1473-3099(22)00228-6. PMC 9300470 Check |pmc= value (bantuan). PMID 35623380 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Oral Tecovirimat for the Treatment of Smallpox". The New England Journal of Medicine. 379 (1): 44–53. July 2018. doi:10.1056/NEJMoa1705688. PMC 6086581. PMID 29972742. Unknown parameter |displayauthors= ignored (bantuan)
"Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (42): 943–946. October 2019. doi:10.15585/mmwr.mm6842a2. PMC 6812835. PMID 31647789. Diarkibkan daripada yang asal (PDF) pada 2 Ogos 2022. Dicapai pada 2 Ogos 2022. Unknown parameter |displayauthors= ignored (bantuan)
"Are we there yet? The smallpox research agenda using variola virus". PLOS Pathogens. 10 (5): e1004108. May 2014. doi:10.1371/journal.ppat.1004108. PMC 4006926. PMID 24789223.
"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge". Journal of Virology. 79 (20): 13139–13149. October 2005. doi:10.1128/JVI.79.20.13139-13149.2005. PMC 1235851. PMID 16189015. Unknown parameter |displayauthors= ignored (bantuan)
"Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor". Antimicrobial Agents and Chemotherapy. 52 (5): 1721–1727. May 2008. doi:10.1128/AAC.01303-07. PMC 2346641. PMID 18316519. Unknown parameter |displayauthors= ignored (bantuan)

dailymed.nlm.nih.gov

"Tpoxx- tecovirimat monohydrate capsule". DailyMed. 2 Disember 2021. Diarkibkan daripada yang asal pada 23 April 2022. Dicapai pada 23 April 2022.

nytimes.com

"Drug to Treat Smallpox Approved by F.D.A., a Move Against Bioterrorism". The New York Times. 13 Julai 2018. Diarkibkan daripada yang asal pada 28 Mac 2019. Dicapai pada 16 Julai 2018.

sciencenews.org

"FDA approves the first smallpox treatment". 13 Julai 2018. Diarkibkan daripada yang asal pada 12 Julai 2018. Dicapai pada 4 Mei 2018.

siga.com

investor.siga.com

"U.S. Food and Drug Administration Approves Siga Technologies' Tpoxx (tecovirimat) for the Treatment of Smallpox" (Siaran akhbar). Diarkibkan daripada yang asal pada 21 September 2018. Dicapai pada 14 Julai 2018.
"Siga Announces Health Canada Regulatory Approval of Oral Tpoxx" (Siaran akhbar). Siga Technologies. 1 Disember 2021. Diarkibkan daripada yang asal pada 24 Mei 2022. Dicapai pada 24 Mei 2022.

siga.com

"Siga Technologies". Diarkibkan daripada yang asal pada 20 Februari 2012. Dicapai pada 18 September 2009.

web.archive.org

"Notice: Multiple Additions to the Prescription Drug List (PDL) [2022-01-24]". Health Canada. 24 Januari 2022. Diarkibkan daripada yang asal pada 29 Mei 2022. Dicapai pada 28 Mei 2022.
"New Medicines Approved in 2018". Health Canada. 15 Januari 2020. Diarkibkan daripada yang asal pada 29 Mei 2022. Dicapai pada 28 Mei 2022.
"Summary Basis of Disision (SBD) for Tpoxx". Health Canada. 23 Oktober 2014. Diarkibkan daripada yang asal pada 29 Mei 2022. Dicapai pada 29 Mei 2022.
"Tpoxx- tecovirimat monohydrate capsule". DailyMed. 2 Disember 2021. Diarkibkan daripada yang asal pada 23 April 2022. Dicapai pada 23 April 2022.
"Tecovirimat Siga EPAR". European Medicines Agency. 10 November 2021. Diarkibkan daripada yang asal pada 16 Mei 2022. Dicapai pada 23 April 2022.
"Drug to Treat Smallpox Approved by F.D.A., a Move Against Bioterrorism". The New York Times. 13 Julai 2018. Diarkibkan daripada yang asal pada 28 Mac 2019. Dicapai pada 16 Julai 2018.
"FDA approves the first drug with an indication for treatment of smallpox" (Siaran akhbar). 13 Julai 2018. Diarkibkan daripada yang asal pada 23 April 2019. Dicapai pada 1 Ogos 2018.
"U.S. Food and Drug Administration Approves Siga Technologies' Tpoxx (tecovirimat) for the Treatment of Smallpox" (Siaran akhbar). Diarkibkan daripada yang asal pada 21 September 2018. Dicapai pada 14 Julai 2018.
"Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (42): 943–946. October 2019. doi:10.15585/mmwr.mm6842a2. PMC 6812835. PMID 31647789. Diarkibkan daripada yang asal (PDF) pada 2 Ogos 2022. Dicapai pada 2 Ogos 2022. Unknown parameter |displayauthors= ignored (bantuan)
"FDA approves the first smallpox treatment". 13 Julai 2018. Diarkibkan daripada yang asal pada 12 Julai 2018. Dicapai pada 4 Mei 2018.
"Siga Technologies". Diarkibkan daripada yang asal pada 20 Februari 2012. Dicapai pada 18 September 2009.
Office of the Commissioner (24 Mac 2020). "Press Announcements - FDA approves the first drug with an indication for treatment of smallpox". Food and Drug Administration (FDA). Diarkibkan daripada yang asal pada 23 April 2019. Dicapai pada 14 Julai 2018.
National Institute of Allergy and Infectious Diseases (NIAID) (12 September 2022). "A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Monkeypox Virus Disease". SIGA Technologist. Diarkibkan daripada yang asal pada 20 September 2022. Dicapai pada 16 September 2022.
"Trial Launching to Study Tecovirimat as Monkeypox Treatment". Contagion Live (dalam bahasa Inggeris). 16 September 2022. Diarkibkan daripada yang asal pada 16 September 2022. Dicapai pada 16 September 2022.
"Tecovirimat Siga: Pending EC decision". European Medicines Agency. 11 November 2021. Diarkibkan daripada yang asal pada 13 November 2021. Dicapai pada 13 November 2021.
"Summary of Product Characteristics" (PDF). European Medicines Agency. Diarkibkan (PDF) daripada yang asal pada 21 Mei 2022. Dicapai pada 24 Mei 2022.
"Siga Announces Health Canada Regulatory Approval of Oral Tpoxx" (Siaran akhbar). Siga Technologies. 1 Disember 2021. Diarkibkan daripada yang asal pada 24 Mei 2022. Dicapai pada 24 Mei 2022.
"Information for Healthcare Providers on Obtaining and Using TPOXX (Tecovirimat) for Treatment of Monkeypox". U.S. Centers for Disease Control and Prevention (CDC). 22 Julai 2022. Diarkibkan daripada yang asal pada 31 Julai 2022. Dicapai pada 1 Ogos 2022.
"Steps for Clinicians to Order Medication to Treat Monkeypox". Coca Now. 19 Julai 2022. Diarkibkan daripada yang asal pada 2 Ogos 2022. Dicapai pada 24 Julai 2022.
"Monkeypox Outbreak: Updates on the Epidemiology, Testing, Treatment, and Vaccination" (PDF). U.S. Centers for Disease Control and Prevention. Diarkibkan (PDF) daripada yang asal pada 2 Ogos 2022. Dicapai pada 27 Julai 2022.

wikipedia.org

en.wikipedia.org

"Waking up to monkeypox". BMJ. 377: o1321. May 2022. doi:10.1136/bmj.o1321. PMID 35613732 Check |pmid= value (bantuan).
"Clinical features and management of human monkeypox: a retrospective observational study in the UK". The Lancet. Infectious Diseases. 22 (8): 1153–1162. May 2022. doi:10.1016/S1473-3099(22)00228-6. PMC 9300470 Check |pmc= value (bantuan). PMID 35623380 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Oral Tecovirimat for the Treatment of Smallpox". The New England Journal of Medicine. 379 (1): 44–53. July 2018. doi:10.1056/NEJMoa1705688. PMC 6086581. PMID 29972742. Unknown parameter |displayauthors= ignored (bantuan)
"Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (42): 943–946. October 2019. doi:10.15585/mmwr.mm6842a2. PMC 6812835. PMID 31647789. Diarkibkan daripada yang asal (PDF) pada 2 Ogos 2022. Dicapai pada 2 Ogos 2022. Unknown parameter |displayauthors= ignored (bantuan)
(PDF) |format= requires |url= (bantuan) (Laporan). Diarkibkan daripada yang asal |archive-url= requires |url= (bantuan) pada 17 September 2020. Missing or empty |title= (bantuan)
"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge". Journal of Virology. 79 (20): 13139–13149. October 2005. doi:10.1128/JVI.79.20.13139-13149.2005. PMC 1235851. PMID 16189015. Unknown parameter |displayauthors= ignored (bantuan)
"Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor". Antimicrobial Agents and Chemotherapy. 52 (5): 1721–1727. May 2008. doi:10.1128/AAC.01303-07. PMC 2346641. PMID 18316519. Unknown parameter |displayauthors= ignored (bantuan)